Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 12/20 | 0.42 |
| ▸ | TLR7 | Q9NYK1 | 4/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 3/20 | 0.33 |
| ▸ | TLR4 | O00206 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20134852 | 0.69 | TLR8 (0.60) | TLR8TLR7TLR9TLR4IRAK4 | |
| Hydrochloric Acid SCHEMBL28215651 | 0.68 | TLR8 (0.59) | TLR8TLR7TLR9TLR4IRAK4 | |
| SCHEMBL31065773 | 0.68 | SUV39H2 (0.34) | IRAK4 | |
| SCHEMBL31065746 | 0.67 | MAPK1 (0.31) | MAPK1HSD17B10L3MBTL1 | |
| SCHEMBL31065802 | 0.66 | SMN1; SMN2 (0.40) | MAPK1HSD17B10L3MBTL1 | |
| SCHEMBL31065797 | 0.66 | SMN1; SMN2 (0.40) | MAPK1HSD17B10L3MBTL1 | |
| SCHEMBL20135691 | 0.65 | TLR8 (0.57) | TLR8TLR7TLR9TLR4IRAK4 | |
| SCHEMBL20135108 | 0.65 | TLR8 (0.57) | TLR8TLR7TLR9TLR4IRAK4 | |
| SCHEMBL31065794 | 0.64 | SMN1; SMN2 (0.38) | MAPK1HSD17B10L3MBTL1 | |
| SCHEMBL31065753 | 0.64 | KAT2B (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239959-A | Cyclopropane TLR7 and 8 inhibitor and preparation method and application thereof | 上海深势唯思科技有限责任公司 | 2024-06-25 | — | — | CN | disclosed |